Balyasny Asset Management
BIOA

Balyasny Asset Management’s BioAge Labs BIOA Stock Holding History

Balyasny Asset Management’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$23.2M Buy
+1,327,545
New +$25.6M 0.03% 623
2024
Q4 		– Sell
-120,000
Closed -$2.5M – 3354
2024
Q3 		$2.5M Buy
+120,000
New +$2.4M ﹤0.01% 1585

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

Balyasny Asset Management's BIOA Position: Q1 2026 in Review

Balyasny Asset Management opened a new position in BioAge Labs (BIOA) in Q1 2026: 1,327,545 shares worth $23.2M. The stake represents 0.03% of the portfolio and ranks #623 among its holdings. This is a return to the name: Balyasny Asset Management previously reported a position in BIOA as recently as Q3 2024.

Balyasny Asset Management first reported a position in BIOA in Q3 2024 and has held it in 2 quarters since. 144 funds tracked by Wall St. Rank hold BIOA as of Q1 2026.

  • Balyasny Asset Management held 1,327,545 shares of BioAge Labs worth $23.2M as of Q1 2026.
  • BioAge Labs was a new Balyasny Asset Management position in Q1 2026.
  • BioAge Labs made up 0.03% of Balyasny Asset Management's portfolio in Q1 2026, its #623 holding.
  • Balyasny Asset Management first reported a position in BioAge Labs in Q3 2024 and has held it in 2 quarters since.
  • 144 funds tracked by Wall St. Rank held BioAge Labs as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.